Head and Neck Protocol - RTOG-1216

RTOG-1216

STUDY SUSPENDED 2/26/2016

Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck.